Also, the frequency of mutations seen here is comparable to the previously reported frequency in MSI-positive colorectal cancer [23,24] and emphasizes the importance of ACVR2A and TGF-β signaling in MSI-positive GC, while unraveling the oncogenic roles of RPL22 and LMAN1 requires further investigation. This evidence concerns the gene TGFB1 and colorectal cancer.